Ajou University repository

Frontiers in Oncology
ISSN
  • P2234-943X
Publisher

Frontiers Media S.A.

Listed on
(Coverage)

JCR2017-2023

SJR2012-2020;2022-2023

CiteScore2012-2023

SCIE2017-2024

CC2017-2024

SCOPUS2017-2024

DOAJ2017-2024

EMBASE2016-2024

OA Info.
OA oa mark

based on the information

  • 2017;2018;2019;2020;2021;2022;2023;2024;2025;
Keywords cancer research, clinical oncology, cancer genetics, molecular targets, surgical oncology
Review Process Anonymous peer review
Journal info.
pages
Licences CC BY
Copyrights Yes
DOAJ Coverage Added on Date : 2012-08-14T16:00:33Z
Subject(s) Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Active
Active

based on the information

  • SCOPUS:2024-10
Country
SWITZERLAND
Aime & Scopes
Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. The journal welcomes outstanding contributions in any domain of cancer research: from basic laboratory research to clinical investigation, from prevention to treatment, and from imaging studies to novel treatment strategies.
Homepage
https://www.frontiersin.org/journals/oncology# 
Article List

Showing results 1 to 6 of 6

Corrigendum: miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer(Front. Oncol., (2022), 12, (945057), 10.3389/fonc.2022.945057)oa mark
  • Choi, Sujin;
  • Lee, Soonchul;
  • Han, Young Hoon;
  • Choi, Junwon;
  • Kim, Isaac;
  • Lee, Jusung;
  • An, Hyun Ju
  • 2024-01-01
  • Frontiers in Oncology, Vol.14
  • Frontiers Media SA
Increased risk of cardiovascular disease among kidney cancer survivors: a nationwide population-based cohort studyoa mark
  • Jung, Minji;
  • Choo, Eunjung;
  • Li, Shufeng;
  • Deng, Zhengyi;
  • Li, Jinhui;
  • Li, Mingyi;
  • Basran, Satvir;
  • Lee, Sukhyang;
  • Langston, Marvin E.;
  • Chung, Benjamin I.
  • 2024-01-01
  • Frontiers in Oncology, Vol.14
  • Frontiers Media SA
Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug libraryoa mark
  • Oh, Jisun;
  • An, Hyun−Ju;
  • Yeo, Hyun Jeong;
  • Choi, Sujin;
  • Oh, Jisu;
  • Kim, Segi;
  • Kim, Jin Man;
  • Choi, Junwon;
  • Lee, Soonchul
  • 2022-08-18
  • Frontiers in Oncology, Vol.12
  • Frontiers Media S.A.
miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate canceroa mark
  • Choi, Sujin;
  • Lee, Soonchul;
  • Han, Young Hoon;
  • Choi, Junwon;
  • Kim, Isaac;
  • Lee, Jusung;
  • An, Hyun Ju
  • 2022-08-18
  • Frontiers in Oncology, Vol.12
  • Frontiers Media SA
A Novel Scoring System for Response of Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer Using Early-Treatment Blood Features Derived From Machine Learningoa mark
  • Kim, Jaesik;
  • Sohn, Kyung Ah;
  • Kwak, Jung Hak;
  • Kim, Min Jung;
  • Ryoo, Seung Bum;
  • Jeong, Seung Yong;
  • Park, Kyu Joo;
  • Kang, Hyun Cheol;
  • Chie, Eui Kyu;
  • Jung, Sang Hyuk;
et al
  • 2021-11-29
  • Frontiers in Oncology, Vol.11
  • Frontiers Media S.A.
A Diagnostic Method for Gastric Cancer Using Two-Photon Microscopy With Enzyme-Selective Fluorescent Probes: A Pilot Studyoa mark
  • Noh, Choong Kyun;
  • Lim, Chang Su;
  • Lee, Gil Ho;
  • Cho, Myung Ki;
  • Lee, Hyo Won;
  • Roh, Jin;
  • Kim, Young Bae;
  • Lee, Eunyoung;
  • Park, Bumhee;
  • Kim, Hwan Myung;
et al
  • 2021-08-27
  • Frontiers in Oncology, Vol.11
  • Frontiers Media S.A.
1